ORMP icon

Oramed Pharmaceuticals

61 hedge funds and large institutions have $9.3M invested in Oramed Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 9 increasing their positions, 21 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more ownership

Funds ownership:

less funds holding

Funds holding:

less first-time investments, than exits

New positions opened: | Existing positions closed:

57% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 21

78% less capital invested

Capital invested by funds: $43.2M → $9.3M (-$33.9M)

Holders
61
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$314K
Puts
$81K
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
26
$40K
27
$39.5K
28
$39.3K
29
$37.9K
30
$31.2K
31
$30.9K
32
$29.2K
33
$28.3K
34
$28K
35
$26K
36
$25.2K
37
$23K
38
$22K
39
$19K
40
$13.9K
41
$12.3K
42
$12K
43
$11.6K
44
$11K
45
$8.94K
46
$6.54K
47
$3.43K
48
$3.05K
49
$2.33K
50
$2.18K